Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | DPP4 | P27487 | 1/20 | 0.44 |
| ▸ | TPH1 | P17752 | 1/20 | 0.44 |
| ▸ | TPH2 | Q8IWU9 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6948261 | 0.81 | HSD17B10 (0.55) | ALDH1A1NPSR1TSHRGAAL3MBTL1 | |
| SCHEMBL515834 | 0.80 | KDM4E (0.54) | ALDH1A1NPSR1TSHRGAAL3MBTL1 | |
| SCHEMBL515910 | 0.80 | GAA (0.53) | ALDH1A1NPSR1TSHRGAAL3MBTL1 | |
| SCHEMBL315739 | 0.78 | HSD17B10 (0.56) | ALDH1A1NPSR1TSHRGAAL3MBTL1 | |
| SCHEMBL19013585 | 0.77 | KDM4E (0.55) | ALDH1A1NPSR1TSHRGAAL3MBTL1 | |
| SCHEMBL11293663 | 0.77 | L3MBTL1 (0.57) | ALDH1A1NPSR1TSHRGAAL3MBTL1 | |
| SCHEMBL8952332 | 0.76 | ALDH1A1 (0.52) | ALDH1A1NPSR1GAAL3MBTL1HSD17B10 | |
| SCHEMBL6944694 | 0.76 | SMN1; SMN2 (0.56) | ALDH1A1NPSR1TSHRGAAL3MBTL1 | |
| SCHEMBL10394507 | 0.75 | RXFP1 (0.63) | ALDH1A1NPSR1TSHRHSD17B10MAPK1 | |
| SCHEMBL11290176 | 0.75 | KDM4E (0.59) | ALDH1A1NPSR1TSHRGAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023039578-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | OMEROS CORPORATION (US) | 2023-03-16 | — | — | WO | claimed |
| EP-3634421-A1 | HDAC1/2 ACTIVATOR FOR PROMOTING AND/OR ACCELERATING MYELINATION AND/OR REMYELINATION | Université de Fribourg (CH) | 2020-04-15 | — | — | EP | claimed |
| WO-2018224650-A1 | HDAC1/2 ACTIVATOR FOR PROMOTING AND/OR ACCELERATING MYELINATION AND/OR REMYELINATION | UNIVERSITE DE FRIBOURG (CH) | 2018-12-13 | — | — | WO | claimed |
| WO-2010065959-A1 | METHOD OF PREPARING ADENOSINE-RESISTANT ANTI-TUMOR T LYMPHOCYTES FOR ADOPTIVE IMMUNOTHERAPY | NORTHEASTERN UNIVERSITY (US) | 2010-06-10 | — | — | WO | claimed |
| EP-2111231-A2 | METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE RESPONSES | NorthEastern University (US) | 2009-10-28 | — | — | EP | claimed |
| EP-1765352-A4 | ANTAGONIZING AN ADENOSINE A2A RECEPTOR TO AMELIORIATE ONE OR MORE COMPONENTS OF ADDICTIVE BEHAVIOR | UNIV CALIFORNIA (US) | 2009-07-08 | — | — | EP | claimed |
| WO-2008147482-A2 | METHODS AND COMPOSITIONS FOR IMPROVING IMMUNE RESPONSES | NORTHEASTERN UNIVERSITY (US) | 2008-12-04 | — | — | WO | claimed |
| EP-1765352-A2 | ANTAGONIZING AN ADENOSINE A2A RECEPTOR TO AMELIORIATE ONE OR MORE COMPONENTS OF ADDICTIVE BEHAVIOR | The Regents of the University of California (US) | 2007-03-28 | — | — | EP | claimed |
| WO-2006009698-A2 | ANTAGONIZING AN ADENOSINE A2A RECEPTOR TO AMELIORIATE ONE OR MORE COMPONENTS OF ADDICTIVE BEHAVIOR | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-01-26 | — | — | WO | claimed |
| EP-1305328-A2 | MATERIALS AND METHODS FOR BINDING NUCLEIC ACIDS TO SURFACES | Lyles, Mark B. (US) | 2003-05-02 | — | — | EP | claimed |
| WO-2002008237-A2 | MATERIALS AND METHODS FOR BINDING NUCLEIC ACIDS TO SURFACES | LYLES MARK B (US) | 2002-01-31 | — | — | WO | claimed |
| WO-2024129778-A2 | CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR BAFF-R AND CD19 AND METHODS AND USES THEREOF | JUNO THERAPEUTICS, INC. (US) | 2024-06-20 | — | — | WO | disclosed |
| WO-2024031091-A2 | CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR GPRC5D AND BCMA | JUNO THERAPEUTICS, INC. (US) | 2024-02-08 | — | — | WO | disclosed |
| WO-2023250400-A1 | TREATMENT METHODS FOR SECOND LINE THERAPY OF CD19-TARGETED CAR T CELLS | JUNO THERAPEUTICS, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023039578-A1 | METHODS AND COMPOSITIONS FOR TREATING CANCER | OMEROS CORPORATION (US) | 2023-03-16 | — | — | WO | disclosed |
| US-5932558-A | PROMOTE MIGRATION OF ENDOTHELIAL CELLS, FIBROBLASTS AND EPITHELIAL CELLS | NEW YORK UNIVERSITY (US) | 1999-08-03 | — | — | US | disclosed |
| EP-0814810-A4 | ADENOSINE AS A POSITIVE INOTROP IN THE COMPROMISED HEART | UNIV MASSACHUSETTS MEDICAL (US) | 1999-06-09 | — | — | EP | disclosed |
| EP-0814810-A1 | ADENOSINE AS A POSITIVE INOTROP IN THE COMPROMISED HEART | UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER (US) | 1998-01-07 | — | — | EP | disclosed |
| WO-1996028163-A1 | ADENOSINE AS A POSITIVE INOTROP IN THE COMPROMISED HEART | UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER (US) | 1996-09-19 | — | — | WO | disclosed |
| WO-1994023723-A1 | ADENOSINE RECEPTOR AGONISTS FOR THE PROMOTION OF WOUND HEALING | NEW YORK UNIVERSITY (US) | 1994-10-27 | — | — | WO | disclosed |